Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Waltham, Massachusetts 02541


Purpose:

To assess positive blood cultures (PBCs) in hemodialysis central venous catheter (CVC) patients using two FDA cleared devices: ClearGuard HD end caps compared to conventional end caps.


Criteria:

Inclusion Criteria: - All patients dialyzing with a central venous catheter Exclusion Criteria: - Known allergy to chlorhexidine


NCT ID:

NCT02604264


Primary Contact:

Principal Investigator
Jeffrey Hymes, MD
Fresenius Medical Care North America


Backup Contact:

N/A


Location Contact:

Waltham, Massachusetts 02541
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.